Results 251 to 260 of about 83,135 (307)

Samidorphan sadness: does the addition of samidorphan to olanzapine have prodepressive effects? [PDF]

Int Clin Psychopharmacol
Parkerson JA, Chaia AI, Lynch ST, Sterchele AN.   +3 more
europepmc   +1 more source

Podcast‐induced reflex seizures: A unique trigger

Epileptic Disorders, EarlyView.
David W. Cao, Roberto Gonzalez, Irfan S. Sheikh, Melissa Huynh Mabry   +3 more
wiley   +1 more source

Online Intensive Short-Term Dynamic Psychotherapy for Treatment-Resistant Somatic Symptom Disorder: An Interrupted Time-Series Study.

Psychother Psychosom
Lilliengren P, Ljungdahl M, Rööst M, Falkenström F, Town JM, Maroti D.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder

Journal of Psychiatric Research, 2011
Treatment-resistant major depressive disorder (MDD) is a complex condition, with very low remission rates. Physical exercise has been used, with some encouraging results, as an alternative therapy in other depressive disorders. This study assessed the impact on depression and functioning parameters of a moderate intensity exercise program, as an ...
Mota-Pereira, Jorge, Silvério, Jorge Manuel Amaral, Carvalho, Serafim, Ribeiro, José Carlos, Fonte, Daniela, Ramos, Joaquim   +5 more
openaire   +5 more sources

Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder

Current Medical Research and Opinion, 2010
Treatment-resistant depression (TRD) imposes substantial cost from the perspective of employers. The objective of this study was to assess direct healthcare costs and indirect (disability and medical-related absenteeism) costs associated with TRD compared with non-treatment-resistant major depressive disorder (MDD).Employees with one or more inpatient,
Jasmina I, Ivanova, Howard G, Birnbaum, Yohanne, Kidolezi, Ganesh, Subramanian, Sajjad A, Khan, Michael D, Stensland   +5 more
openaire   +4 more sources

Brexpiprazole for treatment-resistant major depressive disorder

Expert Opinion on Pharmacotherapy, 2019
Introduction:Treatment-resistant depression (TRD), seldom interchangeably referred to as 'depression inadequately responding to the standard antidepressant drug,' carries a significant burden. The atypical antipsychotics represent a popular augmentation strategy for antidepressant-resistant depression, although their efficacy/safety profiles vary ...
Fornaro M., Fusco A., Anastasia A., Cattaneo C. I., De Berardis D.   +4 more
openaire   +3 more sources

Axis III disorders in treatment-resistant major depressive disorder

Psychiatry Research, 2003
A number of naturalistic studies have found that medical co-morbidity conveys a worse long-term prognosis in the treatment of major depressive disorder (MDD). The purpose of this study was to test whether the presence of co-morbid medical conditions can predict clinical response in patients with treatment-resistant MDD (TRD) treated with open-label ...
George I, Papakostas, Timothy, Petersen, Dan V, Iosifescu, Pamela A, Roffi, Jonathan E, Alpert, Jerrold F, Rosenbaum, Maurizio, Fava, Andrew A, Nierenberg   +7 more
openaire   +2 more sources

Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder

Annals of Pharmacotherapy, 2012
OBJECTIVE: To evaluate the literature regarding the efficacy and safety of intravenous ketamine for treatment-resistant major depressive disorder (MDD). DATA SOURCES: A MEDLINE search (1966-September 2011) was performed using the terms treatment-resistant depression and ketamine.
Jordan R, Covvey, Alexis Noble, Crawford, Denise K, Lowe   +2 more
openaire   +2 more sources